| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP transmembrane transporter activity | 5.33e-08 | 14 | 157 | 5 | GO:0005347 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 5.65e-07 | 39 | 157 | 6 | GO:0015605 | |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 8.46e-07 | 23 | 157 | 5 | GO:0005346 | |
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 1.16e-06 | 11 | 157 | 4 | GO:0015217 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 1.62e-06 | 26 | 157 | 5 | GO:0000295 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 2.87e-06 | 29 | 157 | 5 | GO:0015216 | |
| GeneOntologyMolecularFunction | ATP:ADP antiporter activity | 4.71e-06 | 5 | 157 | 3 | GO:0005471 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 5.60e-06 | 33 | 157 | 5 | GO:0015215 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 6.86e-06 | 59 | 157 | 6 | GO:1901505 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC25A42 SLC25A4 SLC25A5 SLC25A6 SLC7A11 ANKH SLC2A10 MFSD2A SLC5A6 SLC26A6 SLC27A5 | 2.11e-05 | 293 | 157 | 11 | GO:0008514 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ATP5MC3 SLC25A42 AQP12A TPCN2 SLC25A4 SLC25A5 SLC25A6 SLC7A11 AQP6 ANKH CHRNA4 AQP12B SLC2A10 MFSD2A SLC22A16 SLC5A6 ABCB8 LRRC26 PKD1 SLC14A2 ATP2B3 SLC26A6 SLC27A5 | 5.06e-05 | 1180 | 157 | 23 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | ATP5MC3 SLC25A42 AQP12A TPCN2 SLC25A4 SLC25A5 SLC25A6 PEX1 SLC7A11 AQP6 ANKH CHRNA4 AQP12B SLC2A10 MFSD2A SLC22A16 SLC5A6 ABCB8 LRRC26 PKD1 SLC14A2 ATP2B3 SLC26A6 SLC27A5 | 7.02e-05 | 1289 | 157 | 24 | GO:0005215 |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 1.00e-04 | 59 | 157 | 5 | GO:0015932 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC25A42 SLC25A4 SLC25A5 SLC25A6 SLC7A11 ANKH SLC2A10 MFSD2A SLC5A6 SLC26A6 | 1.21e-04 | 296 | 157 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 1.83e-04 | 3 | 157 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | water channel activity | 2.99e-04 | 17 | 157 | 3 | GO:0015250 | |
| GeneOntologyMolecularFunction | N-acetylmuramoyl-L-alanine amidase activity | 3.65e-04 | 4 | 157 | 2 | GO:0008745 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC25A42 SLC25A4 SLC25A5 SLC25A6 SLC7A11 ANKH SLC2A10 MFSD2A SLC5A6 ABCB8 ATP2B3 SLC26A6 | 4.01e-04 | 477 | 157 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | water transmembrane transporter activity | 4.93e-04 | 20 | 157 | 3 | GO:0005372 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 6.05e-04 | 5 | 157 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 6.05e-04 | 5 | 157 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | peptidoglycan immune receptor activity | 6.05e-04 | 5 | 157 | 2 | GO:0016019 | |
| GeneOntologyMolecularFunction | oxidative phosphorylation uncoupler activity | 6.05e-04 | 5 | 157 | 2 | GO:0017077 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP5MC3 AQP12A TPCN2 SLC25A4 SLC25A5 AQP6 ANKH AQP12B SLC2A10 MFSD2A SLC5A6 LRRC26 PKD1 ATP2B3 SLC26A6 | 9.60e-04 | 758 | 157 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | cytokine receptor activity | 1.02e-03 | 97 | 157 | 5 | GO:0004896 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 1.50e-03 | 29 | 157 | 3 | GO:0045499 | |
| GeneOntologyBiologicalProcess | ATP transport | 6.78e-07 | 23 | 155 | 5 | GO:0015867 | |
| GeneOntologyBiologicalProcess | ADP transport | 1.45e-06 | 12 | 155 | 4 | GO:0015866 | |
| GeneOntologyBiologicalProcess | negative chemotaxis | 2.23e-06 | 51 | 155 | 6 | GO:0050919 | |
| GeneOntologyBiologicalProcess | mitochondrial ADP transmembrane transport | 4.12e-06 | 5 | 155 | 3 | GO:0140021 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide transport | 1.20e-05 | 40 | 155 | 5 | GO:0015868 | |
| GeneOntologyBiologicalProcess | adenine nucleotide transport | 1.53e-05 | 42 | 155 | 5 | GO:0051503 | |
| GeneOntologyBiologicalProcess | purine nucleotide transport | 1.93e-05 | 44 | 155 | 5 | GO:0015865 | |
| GeneOntologyBiologicalProcess | mitochondrial ATP transmembrane transport | 2.27e-05 | 8 | 155 | 3 | GO:1990544 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 3.38e-05 | 9 | 155 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | nucleotide transport | 3.62e-05 | 50 | 155 | 5 | GO:0006862 | |
| GeneOntologyBiologicalProcess | negative regulation of chemotaxis | 5.28e-05 | 54 | 155 | 5 | GO:0050922 | |
| GeneOntologyBiologicalProcess | negative regulation of negative chemotaxis | 5.61e-05 | 2 | 155 | 2 | GO:0050925 | |
| GeneOntologyBiologicalProcess | nucleotide transmembrane transport | 8.24e-05 | 31 | 155 | 4 | GO:1901679 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative transport | 8.68e-05 | 96 | 155 | 6 | GO:1901264 | |
| GeneOntologyBiologicalProcess | mammary gland morphogenesis | 1.29e-04 | 65 | 155 | 5 | GO:0060443 | |
| GeneOntologyBiologicalProcess | heart formation | 1.50e-04 | 36 | 155 | 4 | GO:0060914 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SEMA3F PLXNA3 HSPG2 ABL1 OBSL1 LAMA3 SEMA4C MFSD2A AFG3L2 SEC24B PTPRQ PAK3 ROBO1 ROBO2 SCRIB TNR | 1.67e-04 | 748 | 155 | 16 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of mitochondrial ATP synthesis coupled proton transport | 1.67e-04 | 3 | 155 | 2 | GO:1905706 | |
| GeneOntologyBiologicalProcess | regulation of type II interferon production | 1.74e-04 | 155 | 155 | 7 | GO:0032649 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 1.77e-04 | 15 | 155 | 3 | GO:1901029 | |
| GeneOntologyBiologicalProcess | response to vitamin D | 1.86e-04 | 38 | 155 | 4 | GO:0033280 | |
| GeneOntologyBiologicalProcess | synapse organization | SEMA3F SDK2 ABL1 FRMPD4 PCDHGC4 TNC STK38 SLC7A11 SEMA4C AFG3L2 PAK3 ROBO1 ROBO2 NRG3 TNR | 2.09e-04 | 685 | 155 | 15 | GO:0050808 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | SOX5 NCOA3 HSPG2 SDK2 TNC CYP27B1 LAMA3 ITGA6 ANKH MFSD2A CSF3R IFT88 PIM1 SEC24B PTPRQ PKD1 ROBO1 ROBO2 SCRIB CSMD1 NRG3 DNAH11 | 2.09e-04 | 1269 | 155 | 22 | GO:0009887 |
| GeneOntologyBiologicalProcess | inner ear receptor cell development | 2.24e-04 | 73 | 155 | 5 | GO:0060119 | |
| GeneOntologyBiologicalProcess | purine-containing compound transmembrane transport | 2.27e-04 | 40 | 155 | 4 | GO:0072530 | |
| GeneOntologyBiologicalProcess | fluid transport | 2.75e-04 | 42 | 155 | 4 | GO:0042044 | |
| GeneOntologyBiologicalProcess | type II interferon production | 2.95e-04 | 169 | 155 | 7 | GO:0032609 | |
| GeneOntologyBiologicalProcess | negative regulation of adenylate cyclase activity | 3.13e-04 | 18 | 155 | 3 | GO:0007194 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell differentiation | 3.33e-04 | 4 | 155 | 2 | GO:0032824 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell differentiation involved in immune response | 3.33e-04 | 4 | 155 | 2 | GO:0032827 | |
| GeneOntologyBiologicalProcess | receptor transactivation | 3.33e-04 | 4 | 155 | 2 | GO:0035624 | |
| GeneOntologyBiologicalProcess | regulation of negative chemotaxis | 3.33e-04 | 4 | 155 | 2 | GO:0050923 | |
| GeneOntologyBiologicalProcess | cochlear nucleus development | 3.33e-04 | 4 | 155 | 2 | GO:0021747 | |
| GeneOntologyBiologicalProcess | mammary gland duct morphogenesis | 3.60e-04 | 45 | 155 | 4 | GO:0060603 | |
| GeneOntologyBiologicalProcess | negative regulation of cyclase activity | 3.69e-04 | 19 | 155 | 3 | GO:0031280 | |
| GeneOntologyBiologicalProcess | cell junction organization | SEMA3F SDK2 ABL1 FRMPD4 PCDHGC4 TNC STK38 LAMA3 ITGA6 SLC7A11 SVEP1 SEMA4C AFG3L2 PAK3 ROBO1 ROBO2 NRG3 TNR | 3.89e-04 | 974 | 155 | 18 | GO:0034330 |
| GeneOntologyBiologicalProcess | organic anion transport | SLC25A42 SLC25A4 SLC25A5 SLC25A6 SLC7A11 ANKH ARG2 SLC2A10 MFSD2A SLC5A6 SLC26A6 SLC27A5 | 5.31e-04 | 515 | 155 | 12 | GO:0015711 |
| GeneOntologyBiologicalProcess | natural killer cell differentiation involved in immune response | 5.53e-04 | 5 | 155 | 2 | GO:0002325 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation involved in immune response | 5.53e-04 | 5 | 155 | 2 | GO:0032826 | |
| GeneOntologyBiologicalProcess | head development | PLXNA3 HSPG2 ABL1 DNAJC30 PFAS SLC7A11 SEMA4C MFSD2A IFT88 SEC24B ROBO1 ROBO2 HSD3B1 PRKDC SCRIB NRG3 TNR | 5.62e-04 | 919 | 155 | 17 | GO:0060322 |
| GeneOntologyBiologicalProcess | negative regulation of lyase activity | 5.77e-04 | 22 | 155 | 3 | GO:0051350 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SEMA3F PLXNA3 HSPG2 ABL1 OBSL1 LAMA3 PRAG1 SEMA4C LIFR MFSD2A IFT88 AFG3L2 SEC24B PTPRQ PAK3 ROBO1 ROBO2 PRKDC SCRIB TNR | 6.41e-04 | 1194 | 155 | 20 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection development | SEMA3F PLXNA3 HSPG2 ABL1 TNC OBSL1 LAMA3 ITGA6 ADGRV1 PRAG1 SEMA4C LIFR MFSD2A IFT88 AFG3L2 SEC24B PAK3 ROBO1 ROBO2 SCRIB TNR | 6.41e-04 | 1285 | 155 | 21 | GO:0031175 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ATPSCKMT ATP5MC3 TPCN2 ABL1 SLC25A4 SLC25A5 AQP6 ANKH SLC2A10 LIME1 ADRA2A SLC5A6 ABCB8 AFG3L2 LRRC26 PKD1 ATP2B3 SLC26A6 | 6.46e-04 | 1017 | 155 | 18 | GO:0098660 |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial membrane permeability | 6.60e-04 | 23 | 155 | 3 | GO:0035795 | |
| GeneOntologyBiologicalProcess | regulation of sensory perception of pain | 6.60e-04 | 23 | 155 | 3 | GO:0051930 | |
| GeneOntologyBiologicalProcess | cellular response to vitamin D | 6.60e-04 | 23 | 155 | 3 | GO:0071305 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell stereocilium organization | 6.75e-04 | 53 | 155 | 4 | GO:0060122 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | PLXNA3 HSPG2 SDK2 ABL1 CYP27B1 OBSL1 SRPK2 SBNO2 SEMA4C CSF3R IFT88 PIM1 SEC24B PKD1 TMOD1 ROBO1 ROBO2 PRKDC SCRIB NRG3 VAV2 CCN3 MYBPC2 | 7.18e-04 | 1483 | 155 | 23 | GO:0048646 |
| GeneOntologyBiologicalProcess | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 7.50e-04 | 24 | 155 | 3 | GO:1901028 | |
| GeneOntologyBiologicalProcess | regulation of sensory perception | 7.50e-04 | 24 | 155 | 3 | GO:0051931 | |
| GeneOntologyBiologicalProcess | brain development | PLXNA3 HSPG2 ABL1 DNAJC30 SLC7A11 SEMA4C MFSD2A IFT88 SEC24B ROBO1 ROBO2 HSD3B1 PRKDC SCRIB NRG3 TNR | 7.63e-04 | 859 | 155 | 16 | GO:0007420 |
| GeneOntologyBiologicalProcess | regulation of growth | SEMA3F PLXNA3 NCOA3 FLT3 ABL1 SLC25A4 TNC CYP27B1 MFSD2A PIM1 AFG3L2 PRKDC NRG3 TNR CCN3 | 7.80e-04 | 777 | 155 | 15 | GO:0040008 |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 7.92e-04 | 96 | 155 | 5 | GO:0060113 | |
| GeneOntologyBiologicalProcess | blood coagulation | 8.00e-04 | 260 | 155 | 8 | GO:0007596 | |
| GeneOntologyBiologicalProcess | peptidoglycan metabolic process | 8.25e-04 | 6 | 155 | 2 | GO:0000270 | |
| GeneOntologyBiologicalProcess | peptidoglycan catabolic process | 8.25e-04 | 6 | 155 | 2 | GO:0009253 | |
| GeneOntologyBiologicalProcess | trigeminal nerve morphogenesis | 8.25e-04 | 6 | 155 | 2 | GO:0021636 | |
| GeneOntologyBiologicalProcess | trigeminal nerve structural organization | 8.25e-04 | 6 | 155 | 2 | GO:0021637 | |
| GeneOntologyBiologicalProcess | adenine transport | 8.25e-04 | 6 | 155 | 2 | GO:0015853 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 3.38e-05 | 9 | 157 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | mitochondrial inner membrane | ATPSCKMT ATP5MC3 SLC25A42 SLC25A4 SLC25A5 SLC25A6 DNAJC30 MDH2 BDH1 NDUFA11 ACAD11 ABCB8 AFG3L2 HSD3B1 UQCRC2 | 4.24e-05 | 593 | 157 | 15 | GO:0005743 |
| GeneOntologyCellularComponent | organelle inner membrane | ATPSCKMT ATP5MC3 SLC25A42 SLC25A4 SLC25A5 SLC25A6 DNAJC30 MDH2 BDH1 NDUFA11 ACAD11 ABCB8 AFG3L2 HSD3B1 UQCRC2 | 1.22e-04 | 652 | 157 | 15 | GO:0019866 |
| GeneOntologyCellularComponent | ER membrane insertion complex | 1.42e-04 | 14 | 157 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | tenascin complex | 3.33e-04 | 4 | 157 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | mitochondrial envelope | ATPSCKMT ATP5MC3 SLC25A42 SLC25A4 SLC25A5 SLC25A6 DNAJC30 CYP27B1 MDH2 BDH1 NDUFA11 ACAD11 ABCB8 AFG3L2 HSD3B1 UQCRC2 NBR1 | 5.15e-04 | 912 | 157 | 17 | GO:0005740 |
| GeneOntologyCellularComponent | MMXD complex | 5.52e-04 | 5 | 157 | 2 | GO:0071817 | |
| GeneOntologyCellularComponent | mitochondrial membrane | ATPSCKMT ATP5MC3 SLC25A42 SLC25A4 SLC25A5 SLC25A6 DNAJC30 CYP27B1 MDH2 BDH1 NDUFA11 ACAD11 ABCB8 AFG3L2 HSD3B1 UQCRC2 | 8.30e-04 | 866 | 157 | 16 | GO:0031966 |
| GeneOntologyCellularComponent | mitochondrial permeability transition pore complex | 1.15e-03 | 7 | 157 | 2 | GO:0005757 | |
| MousePheno | abnormal joint physiology | 4.27e-06 | 145 | 120 | 9 | MP:0031169 | |
| MousePheno | disproportionate dwarf | 8.96e-06 | 57 | 120 | 6 | MP:0002427 | |
| MousePheno | joint inflammation | 1.67e-05 | 131 | 120 | 8 | MP:0002933 | |
| MousePheno | abnormal chest morphology | 1.95e-05 | 39 | 120 | 5 | MP:0004134 | |
| MousePheno | abnormal spinal cord lateral column morphology | 7.31e-05 | 2 | 120 | 2 | MP:0009678 | |
| MousePheno | abnormal gland physiology | TPO AQP12A TPCN2 ATR STK38 AQP12B ARFGEF3 TRIB3 IFT88 LRRC26 PKD1 ROBO1 HSD3B1 IL1RL1 PRKDC SCRIB VAV2 | 8.30e-05 | 691 | 120 | 17 | MP:0002164 |
| MousePheno | increased circulating tumor necrosis factor level | 8.88e-05 | 85 | 120 | 6 | MP:0008553 | |
| MousePheno | abnormal skeleton physiology | SOX5 NID2 HSPG2 FAM210A SH3BP2 MATN3 CYP27B1 PFAS PGLYRP2 PAPSS2 ANKH SBNO2 PKD1 NBR1 CCN3 IL27RA | 9.82e-05 | 632 | 120 | 16 | MP:0001533 |
| MousePheno | abnormal limb long bone morphology | TPO HSPG2 SH3BP2 MATN3 CYP27B1 ADGRV1 ANKH LIFR RGN IFT88 PKD1 HHIPL1 TMEM86A NBR1 CCN3 | 1.04e-04 | 568 | 120 | 15 | MP:0011504 |
| MousePheno | abnormal skeleton development | HSPG2 ATR SH3BP2 MATN3 CYP27B1 PFAS PAPSS2 ANKH SBNO2 RGN PKD1 NBR1 CCN3 | 1.20e-04 | 447 | 120 | 13 | MP:0002113 |
| MousePheno | abnormal bone ossification | SOX5 HSPG2 FAM210A SH3BP2 CYP27B1 PFAS PAPSS2 ANKH SBNO2 PKD1 NBR1 CCN3 | 1.48e-04 | 395 | 120 | 12 | MP:0008271 |
| MousePheno | abnormal limb bone morphology | TPO HSPG2 SH3BP2 MATN3 CYP27B1 ADGRV1 ANKH LIFR RGN IFT88 PKD1 HHIPL1 TMEM86A NBR1 CCN3 | 1.49e-04 | 587 | 120 | 15 | MP:0002115 |
| MousePheno | limbs/digits/tail phenotype | TPO HSPG2 FLT3 TPCN2 SH3BP2 MATN3 CYP27B1 PFAS ADGRV1 PAPSS2 ANKH SVEP1 LIFR RGN IFT88 SEC24B PKD1 HHIPL1 SCRIB TMEM86A NBR1 CCN3 DNAH11 MYBPC2 | 1.49e-04 | 1258 | 120 | 24 | MP:0005371 |
| MousePheno | abnormal tumor necrosis factor level | 1.66e-04 | 181 | 120 | 8 | MP:0008752 | |
| MousePheno | decreased cranium height | 1.74e-04 | 33 | 120 | 4 | MP:0008525 | |
| MousePheno | abnormal osteoclast morphology | 1.79e-04 | 183 | 120 | 8 | MP:0004982 | |
| MousePheno | abnormal long bone morphology | TPO HSPG2 SH3BP2 MATN3 CYP27B1 ADGRV1 PAPSS2 ANKH LIFR RGN IFT88 PKD1 HHIPL1 TMEM86A NBR1 CCN3 | 2.13e-04 | 676 | 120 | 16 | MP:0003723 |
| MousePheno | premature cranial synchondrosis closure | 2.18e-04 | 3 | 120 | 2 | MP:0030444 | |
| MousePheno | abnormal orientation of cochlear hair cell stereociliary bundles | 2.20e-04 | 35 | 120 | 4 | MP:0004522 | |
| MousePheno | increased susceptibility to induced pancreatitis | 2.60e-04 | 15 | 120 | 3 | MP:0004761 | |
| MousePheno | increased circulating interleukin-6 level | 2.84e-04 | 105 | 120 | 6 | MP:0008596 | |
| MousePheno | decreased chondrocyte proliferation | 3.18e-04 | 16 | 120 | 3 | MP:0014101 | |
| MousePheno | abnormal synchondrosis | 3.18e-04 | 16 | 120 | 3 | MP:0004053 | |
| MousePheno | abnormal endochondral bone ossification | 3.31e-04 | 108 | 120 | 6 | MP:0008272 | |
| MousePheno | abnormal chondrocyte physiology | 4.49e-04 | 42 | 120 | 4 | MP:0009780 | |
| MousePheno | abnormal limb morphology | TPO HSPG2 FLT3 SH3BP2 MATN3 CYP27B1 ADGRV1 PAPSS2 ANKH SVEP1 LIFR RGN IFT88 PKD1 HHIPL1 TMEM86A NBR1 CCN3 DNAH11 MYBPC2 | 4.50e-04 | 1028 | 120 | 20 | MP:0002109 |
| MousePheno | chondrodystrophy | 4.58e-04 | 18 | 120 | 3 | MP:0002657 | |
| MousePheno | abnormal pancreatic acinus morphology | 4.92e-04 | 43 | 120 | 4 | MP:0009145 | |
| MousePheno | abnormal cartilage physiology | 4.92e-04 | 43 | 120 | 4 | MP:0031306 | |
| MousePheno | abnormal circulating interleukin-6 level | 5.09e-04 | 163 | 120 | 7 | MP:0008595 | |
| Domain | Ig-like_fold | SEMA3F PLXNA3 HSPG2 FLT3 SDK2 TNC OBSL1 TGM5 NOMO1 SEMA4C LIFR CILP2 FNDC7 CSF3R PTPRH NOMO2 ROBO1 ROBO2 IL1RL1 TNR NOMO3 IGSF3 IL27RA MYBPC2 | 3.22e-09 | 706 | 153 | 24 | IPR013783 |
| Domain | - | SEMA3F PLXNA3 HSPG2 FLT3 SDK2 TNC OBSL1 TGM5 NOMO1 SEMA4C LIFR CILP2 FNDC7 CSF3R NOMO2 ROBO1 ROBO2 IL1RL1 TNR NOMO3 IGSF3 IL27RA MYBPC2 | 4.86e-09 | 663 | 153 | 23 | 2.60.40.10 |
| Domain | fn3 | SDK2 TNC OBSL1 LIFR FNDC7 CSF3R PTPRH ROBO1 ROBO2 TNR IL27RA MYBPC2 | 9.26e-09 | 162 | 153 | 12 | PF00041 |
| Domain | FN3 | SDK2 TNC OBSL1 LIFR FNDC7 CSF3R PTPRH ROBO1 ROBO2 TNR IL27RA MYBPC2 | 4.09e-08 | 185 | 153 | 12 | SM00060 |
| Domain | FN3 | SDK2 TNC OBSL1 LIFR FNDC7 CSF3R PTPRH ROBO1 ROBO2 TNR IL27RA MYBPC2 | 9.13e-08 | 199 | 153 | 12 | PS50853 |
| Domain | FN3_dom | SDK2 TNC OBSL1 LIFR FNDC7 CSF3R PTPRH ROBO1 ROBO2 TNR IL27RA MYBPC2 | 1.56e-07 | 209 | 153 | 12 | IPR003961 |
| Domain | Carb-bd-like_fold | 2.95e-07 | 8 | 153 | 4 | IPR013784 | |
| Domain | DUF2012 | 2.14e-06 | 4 | 153 | 3 | PF09430 | |
| Domain | DUF2012 | 2.14e-06 | 4 | 153 | 3 | IPR019008 | |
| Domain | CarboxyPept_regulatory_dom | 2.92e-06 | 13 | 153 | 4 | IPR014766 | |
| Domain | - | 2.92e-06 | 13 | 153 | 4 | 2.60.40.1120 | |
| Domain | EGF | 3.85e-06 | 235 | 153 | 11 | SM00181 | |
| Domain | EGF-like_dom | 6.69e-06 | 249 | 153 | 11 | IPR000742 | |
| Domain | EGF | 9.37e-06 | 126 | 153 | 8 | PF00008 | |
| Domain | CarboxyPept-like_regulatory | 9.48e-06 | 17 | 153 | 4 | IPR008969 | |
| Domain | EGF-like_CS | 1.04e-05 | 261 | 153 | 11 | IPR013032 | |
| Domain | EGF_2 | 1.20e-05 | 265 | 153 | 11 | PS01186 | |
| Domain | IGc2 | SEMA3F HSPG2 SDK2 OBSL1 CILP2 ROBO1 ROBO2 IL1RL1 IGSF3 MYBPC2 | 2.45e-05 | 235 | 153 | 10 | SM00408 |
| Domain | EGF_3 | 2.45e-05 | 235 | 153 | 10 | PS50026 | |
| Domain | Ig_sub2 | SEMA3F HSPG2 SDK2 OBSL1 CILP2 ROBO1 ROBO2 IL1RL1 IGSF3 MYBPC2 | 2.45e-05 | 235 | 153 | 10 | IPR003598 |
| Domain | HEMATOPO_REC_L_F2 | 2.93e-05 | 8 | 153 | 3 | PS01353 | |
| Domain | Growth_fac_rcpt_ | 4.40e-05 | 156 | 153 | 8 | IPR009030 | |
| Domain | Aquaporin_12 | 6.67e-05 | 2 | 153 | 2 | IPR023265 | |
| Domain | Mit_uncoupling | 1.12e-04 | 12 | 153 | 3 | IPR002030 | |
| Domain | Mit_carrier | 1.30e-04 | 32 | 153 | 4 | IPR002067 | |
| Domain | Ig_I-set | 1.74e-04 | 190 | 153 | 8 | IPR013098 | |
| Domain | I-set | 1.74e-04 | 190 | 153 | 8 | PF07679 | |
| Domain | MIP | 1.84e-04 | 14 | 153 | 3 | PF00230 | |
| Domain | MIP | 1.84e-04 | 14 | 153 | 3 | PS00221 | |
| Domain | IG | SEMA3F HSPG2 FLT3 SDK2 OBSL1 SEMA4C CILP2 ROBO1 ROBO2 IL1RL1 IGSF3 MYBPC2 | 1.86e-04 | 421 | 153 | 12 | SM00409 |
| Domain | Ig_sub | SEMA3F HSPG2 FLT3 SDK2 OBSL1 SEMA4C CILP2 ROBO1 ROBO2 IL1RL1 IGSF3 MYBPC2 | 1.86e-04 | 421 | 153 | 12 | IPR003599 |
| Domain | Aquaporin_11/12 | 1.99e-04 | 3 | 153 | 2 | IPR016697 | |
| Domain | - | 2.28e-04 | 15 | 153 | 3 | 1.20.1080.10 | |
| Domain | Aquaporin-like | 2.28e-04 | 15 | 153 | 3 | IPR023271 | |
| Domain | MIP | 2.28e-04 | 15 | 153 | 3 | IPR000425 | |
| Domain | EGF_1 | 2.59e-04 | 255 | 153 | 9 | PS00022 | |
| Domain | Ig-like_dom | SEMA3F HSPG2 FLT3 SDK2 OBSL1 SEMA4C CILP2 CSF3R ROBO1 ROBO2 IL1RL1 IGSF3 MYBPC2 | 2.61e-04 | 503 | 153 | 13 | IPR007110 |
| Domain | Amidase_domain | 3.96e-04 | 4 | 153 | 2 | IPR002502 | |
| Domain | PGRP | 3.96e-04 | 4 | 153 | 2 | SM00701 | |
| Domain | Amidase_2 | 3.96e-04 | 4 | 153 | 2 | PF01510 | |
| Domain | Ami_2 | 3.96e-04 | 4 | 153 | 2 | SM00644 | |
| Domain | - | 3.96e-04 | 4 | 153 | 2 | 3.40.80.10 | |
| Domain | PGRP_domain_met/bac | 3.96e-04 | 4 | 153 | 2 | IPR006619 | |
| Domain | PGRP | 3.96e-04 | 4 | 153 | 2 | IPR015510 | |
| Domain | EGF_CA | 5.07e-04 | 122 | 153 | 6 | SM00179 | |
| Domain | 6-blade_b-propeller_TolB-like | 5.41e-04 | 46 | 153 | 4 | IPR011042 | |
| Domain | EGF-like_Ca-bd_dom | 5.53e-04 | 124 | 153 | 6 | IPR001881 | |
| Domain | FATC | 6.56e-04 | 5 | 153 | 2 | PF02260 | |
| Domain | EGF_CA | 7.06e-04 | 86 | 153 | 5 | PF07645 | |
| Domain | IG_LIKE | SEMA3F HSPG2 FLT3 SDK2 OBSL1 SEMA4C CILP2 ROBO1 ROBO2 IL1RL1 IGSF3 MYBPC2 | 7.38e-04 | 491 | 153 | 12 | PS50835 |
| Domain | - | 9.28e-04 | 53 | 153 | 4 | 1.50.40.10 | |
| Domain | Mito_carr | 9.28e-04 | 53 | 153 | 4 | PF00153 | |
| Domain | SOLCAR | 9.28e-04 | 53 | 153 | 4 | PS50920 | |
| Domain | Mitochondrial_sb/sol_carrier | 9.28e-04 | 53 | 153 | 4 | IPR018108 | |
| Domain | Mt_carrier_dom | 9.28e-04 | 53 | 153 | 4 | IPR023395 | |
| Domain | FAT | 9.79e-04 | 6 | 153 | 2 | PS51189 | |
| Domain | FATC | 9.79e-04 | 6 | 153 | 2 | PS51190 | |
| Domain | FAT | 9.79e-04 | 6 | 153 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 9.79e-04 | 6 | 153 | 2 | IPR003151 | |
| Domain | FATC_dom | 9.79e-04 | 6 | 153 | 2 | IPR003152 | |
| Domain | PIK_FAT | 9.79e-04 | 6 | 153 | 2 | IPR014009 | |
| Domain | FATC | 9.79e-04 | 6 | 153 | 2 | SM01343 | |
| Domain | Hematopoietin_rcpt_Gp130_CS | 1.36e-03 | 7 | 153 | 2 | IPR003529 | |
| Domain | Aden_trnslctor | 1.52e-03 | 28 | 153 | 3 | IPR002113 | |
| Domain | LAMININ_IVA | 1.81e-03 | 8 | 153 | 2 | PS51115 | |
| Domain | Laminin_B | 1.81e-03 | 8 | 153 | 2 | PF00052 | |
| Domain | LamB | 1.81e-03 | 8 | 153 | 2 | SM00281 | |
| Domain | Laminin_IV | 1.81e-03 | 8 | 153 | 2 | IPR000034 | |
| Domain | Semap_dom | 2.05e-03 | 31 | 153 | 3 | IPR001627 | |
| Domain | SEMA | 2.05e-03 | 31 | 153 | 3 | PS51004 | |
| Domain | Sema | 2.05e-03 | 31 | 153 | 3 | SM00630 | |
| Domain | Sema | 2.05e-03 | 31 | 153 | 3 | PF01403 | |
| Pathway | REACTOME_MITOCHONDRIAL_PROTEIN_DEGRADATION | 1.78e-05 | 98 | 118 | 7 | M48249 | |
| Pathway | REACTOME_MITOCHONDRIAL_PROTEIN_DEGRADATION | 6.31e-05 | 82 | 118 | 6 | MM17230 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006 | 6.57e-05 | 10 | 118 | 3 | M47694 | |
| Pathway | KEGG_AXON_GUIDANCE | 1.04e-04 | 129 | 118 | 7 | M5539 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.08e-04 | 30 | 118 | 4 | M27216 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 1.19e-04 | 12 | 118 | 3 | M27728 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.54e-04 | 13 | 118 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 1.54e-04 | 13 | 118 | 3 | M47751 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.54e-04 | 13 | 118 | 3 | M47703 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 1.95e-04 | 14 | 118 | 3 | M47692 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 2.42e-04 | 15 | 118 | 3 | M47691 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC25A4 SLC25A5 SLC25A6 SLC7A11 SLC2A10 SLC22A16 SLC5A6 SLC14A2 SLC26A6 | 2.43e-04 | 249 | 118 | 9 | M5988 |
| Pathway | WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA | 2.48e-04 | 105 | 118 | 6 | M39417 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.96e-04 | 16 | 118 | 3 | M47695 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | AQP12A TPCN2 SLC25A4 SLC25A5 SLC25A6 SLC7A11 AQP6 ANKH SLC2A10 SLC22A16 SLC5A6 ABCB8 AFG3L2 SLC14A2 ATP2B3 SLC26A6 | 4.12e-04 | 736 | 118 | 16 | M27287 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.26e-04 | 18 | 118 | 3 | M47659 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 4.26e-04 | 18 | 118 | 3 | M47761 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.34e-04 | 76 | 118 | 5 | M27219 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 4.47e-04 | 43 | 118 | 4 | M881 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 5.02e-04 | 19 | 118 | 3 | M47677 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 5.02e-04 | 19 | 118 | 3 | M47760 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | AQP12A TPCN2 SLC25A4 SLC25A5 SLC7A11 ANKH AQP12B SLC2A10 SLC22A16 SLC5A6 ABCB8 AFG3L2 SLC14A2 ATP2B3 SLC26A6 | 5.52e-04 | 681 | 118 | 15 | MM14985 |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 5.87e-04 | 20 | 118 | 3 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 6.81e-04 | 21 | 118 | 3 | M47689 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 6.83e-04 | 5 | 118 | 2 | M48986 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 6.88e-04 | 84 | 118 | 5 | M7098 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 7.84e-04 | 22 | 118 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 7.84e-04 | 22 | 118 | 3 | M47675 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC25A4 SLC25A5 SLC7A11 SLC2A10 SLC22A16 SLC5A6 SLC14A2 SLC26A6 | 8.71e-04 | 238 | 118 | 8 | MM15076 |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 8.96e-04 | 23 | 118 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.96e-04 | 23 | 118 | 3 | M47676 | |
| Pubmed | SLC25A5 TMEM115 SPTLC1 STT3A NOMO1 SLC5A6 AFG3L2 PRKDC UQCRC2 | 2.61e-09 | 113 | 158 | 9 | 30352685 | |
| Pubmed | HSPG2 SLC25A5 SLC25A6 POLR2B SPTLC1 STK38 STT3A NOMO1 SEMA4C LIFR CILP2 NOMO2 AFG3L2 PRKDC UQCRC2 NOMO3 IGSF3 | 3.39e-09 | 613 | 158 | 17 | 22268729 | |
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 36011023 | ||
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 12450408 | ||
| Pubmed | DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase. | 9.20e-08 | 3 | 158 | 3 | 2541251 | |
| Pubmed | Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver. | 9.20e-08 | 3 | 158 | 3 | 2829183 | |
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 9.20e-08 | 3 | 158 | 3 | 25576386 | |
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 1.18e-07 | 84 | 158 | 7 | 25670202 | |
| Pubmed | Hepatic lipase maturation: a partial proteome of interacting factors. | 2.80e-07 | 31 | 158 | 5 | 19136429 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD8 SLC25A4 SLC25A5 SLC25A6 POLR2B SPTLC1 PFAS MORC4 STT3A NDUFA11 NOMO1 DRG1 UBR5 NOMO2 AFG3L2 MMS19 PRKDC UQCRC2 SCRIB NOMO3 RGPD5 | 2.89e-07 | 1257 | 158 | 21 | 37317656 |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 33396658 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 3.67e-07 | 4 | 158 | 3 | 31833031 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 9267806 | ||
| Pubmed | SEMA3F SLC25A4 POLR2B SPTLC1 STK38 MED14 PEX1 CASP10 PFAS MDH2 STT3A SART1 UBR5 SEC24B TMOD1 VAV2 | 3.85e-07 | 754 | 158 | 16 | 35906200 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | SEMA3F PLXNA3 HSPG2 ATR SPTLC1 ITGA6 PIGG CD320 SLC7A11 STT3A NOMO1 DRG1 PDIA4 LIFR NOMO2 SLC5A6 ROBO1 SCRIB CCN3 IGSF3 | 5.98e-07 | 1201 | 158 | 20 | 35696571 |
| Pubmed | MafB-dependent neurotransmitter signaling promotes β cell migration in the developing pancreas. | 9.32e-07 | 17 | 158 | 4 | 36897571 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | SPTLC1 FRMD8 SNX33 PIGG STT3A THBD FADS3 UBR5 NOMO2 SEC24B ROBO1 MMS19 SCRIB NBR1 IGSF3 | 1.12e-06 | 719 | 158 | 15 | 35337019 |
| Pubmed | Proteomic analysis of the mouse liver mitochondrial inner membrane. | 1.48e-06 | 175 | 158 | 8 | 12865426 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | POLR2B TMEM115 SPTLC1 OBSL1 PEX1 STT3A DRG1 SEMA4C PDIA4 ARFGEF3 UBR5 SEC24B MMS19 PRKDC SCRIB NBR1 NOMO3 | 1.52e-06 | 942 | 158 | 17 | 31073040 |
| Pubmed | SLC25A4 SLC25A5 SLC25A6 TMEM115 SPTLC1 ITGA6 PIGG STT3A NOMO1 SEMA4C PDIA4 NOMO2 SEC24B ROBO1 UQCRC2 SLC26A6 NOMO3 | 1.75e-06 | 952 | 158 | 17 | 38569033 | |
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 10620603 | ||
| Pubmed | SLC25A6 POLR2B SPTLC1 SRPK2 PIGG MDH2 STT3A DRG1 PDIA4 SART1 FADS3 UBR5 NOMO2 AFG3L2 SEC24B ROBO1 MMS19 PRKDC UQCRC2 NBR1 | 1.94e-06 | 1297 | 158 | 20 | 33545068 | |
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 2.42e-06 | 84 | 158 | 6 | 15203218 | |
| Pubmed | 2.98e-06 | 87 | 158 | 6 | 29991678 | ||
| Pubmed | 3.18e-06 | 7 | 158 | 3 | 21370995 | ||
| Pubmed | 3.26e-06 | 50 | 158 | 5 | 23658023 | ||
| Pubmed | SLC25A6 DNAJC30 POLR2B SPTLC1 FNBP4 OBSL1 SRPK2 PFAS MDH2 STT3A NOMO1 DRG1 PDIA4 LIFR UBR5 NOMO2 AFG3L2 ROBO1 UQCRC2 SCRIB NBR1 | 4.16e-06 | 1487 | 158 | 21 | 33957083 | |
| Pubmed | 5.07e-06 | 8 | 158 | 3 | 27641616 | ||
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 5.07e-06 | 8 | 158 | 3 | 15257293 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 7.57e-06 | 9 | 158 | 3 | 36261522 | |
| Pubmed | 7.71e-06 | 28 | 158 | 4 | 18617019 | ||
| Pubmed | 9.20e-06 | 296 | 158 | 9 | 34186245 | ||
| Pubmed | 1.12e-05 | 64 | 158 | 5 | 22865885 | ||
| Pubmed | 1.40e-05 | 67 | 158 | 5 | 30669930 | ||
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 1.40e-05 | 171 | 158 | 7 | 20201926 | |
| Pubmed | 1.48e-05 | 11 | 158 | 3 | 19270065 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 1.48e-05 | 11 | 158 | 3 | 38303699 | |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 1.48e-05 | 11 | 158 | 3 | 32820719 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | RGPD8 SLC25A4 SLC25A5 SLC25A6 POLR2B SPTLC1 OBSL1 PEX1 SRPK2 MDH2 STT3A NDUFA11 ARG2 PDIA4 ARFGEF3 AFG3L2 SEC24B MMS19 UQCRC2 NBR1 | 1.59e-05 | 1496 | 158 | 20 | 32877691 |
| Pubmed | Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. | ATPSCKMT ATP5MC3 SLC25A42 SLC25A4 SLC25A5 SLC25A6 FAM210A DNAJC30 CYP27B1 MDH2 HPDL BDH1 NDUFA11 ARG2 ABCB8 AFG3L2 UQCRC2 | 1.77e-05 | 1136 | 158 | 17 | 34800366 |
| Pubmed | 1.96e-05 | 12 | 158 | 3 | 16120388 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 23415882 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 16287128 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 18285569 | ||
| Pubmed | Robo signaling regulates the production of cranial neural crest cells. | 2.05e-05 | 2 | 158 | 2 | 28987541 | |
| Pubmed | Tenascins and inflammation in disorders of the nervous system. | 2.05e-05 | 2 | 158 | 2 | 23269478 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 28356423 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 18765637 | ||
| Pubmed | DNA structure-specific priming of ATR activation by DNA-PKcs. | 2.05e-05 | 2 | 158 | 2 | 23897887 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 31597096 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 26842067 | ||
| Pubmed | The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. | 2.05e-05 | 2 | 158 | 2 | 14749836 | |
| Pubmed | Human-mouse homologies in the region of the polycystic kidney disease gene (PKD1). | 2.05e-05 | 2 | 158 | 2 | 1349580 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 16262655 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 14585378 | ||
| Pubmed | Tenascins are associated with lipid rafts isolated from mouse brain. | 2.05e-05 | 2 | 158 | 2 | 12056833 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 17311924 | ||
| Pubmed | Robo1/2 regulate follicle atresia through manipulating granulosa cell apoptosis in mice. | 2.05e-05 | 2 | 158 | 2 | 25988316 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 35681468 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 36167651 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 9458045 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 21129254 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 12112115 | ||
| Pubmed | Activation of the intrarenal renin-angiotensin-system in murine polycystic kidney disease. | 2.05e-05 | 2 | 158 | 2 | 25999403 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 35584116 | ||
| Pubmed | Role of adenine nucleotide translocator 1 in mtDNA maintenance. | 2.05e-05 | 2 | 158 | 2 | 10926541 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 19697154 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 8687195 | ||
| Pubmed | Identification of a novel aquaporin, AQP12, expressed in pancreatic acinar cells. | 2.05e-05 | 2 | 158 | 2 | 15809071 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 27048932 | ||
| Pubmed | Robo1 and Robo2 are homophilic binding molecules that promote axonal growth. | 2.05e-05 | 2 | 158 | 2 | 12504588 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 22357859 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 16556444 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 30022126 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 2823266 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 19726746 | ||
| Pubmed | Functional interaction between DNA-PK and c-Abl in response to DNA damage. | 2.05e-05 | 2 | 158 | 2 | 9109492 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 26608094 | ||
| Pubmed | Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes. | 2.05e-05 | 2 | 158 | 2 | 10974536 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 19459213 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 31494663 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 24247621 | ||
| Pubmed | A novel missense adenine nucleotide translocator-1 gene mutation in a Greek adPEO family. | 2.05e-05 | 2 | 158 | 2 | 11756613 | |
| Pubmed | 2.13e-05 | 73 | 158 | 5 | 23464991 | ||
| Pubmed | SLC25A4 DNAJC30 POLR2B SPTLC1 OBSL1 PEX1 PFAS NDUFA11 NOMO1 NOMO2 AFG3L2 NOMO3 | 2.30e-05 | 606 | 158 | 12 | 36538041 | |
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | ATP5MC3 SLC25A42 SLC25A4 SLC25A5 FAM210A DNAJC30 CYP27B1 MDH2 BDH1 NDUFA11 ARG2 ACAD11 ABCB8 AFG3L2 HSD3B1 UQCRC2 | 2.46e-05 | 1047 | 158 | 16 | 18614015 |
| Pubmed | 2.51e-05 | 126 | 158 | 6 | 16284245 | ||
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | SLC25A4 SLC25A5 SLC25A6 STK38 PFAS MDH2 STT3A AFG3L2 PRKDC UQCRC2 | 2.52e-05 | 422 | 158 | 10 | 27342126 |
| Pubmed | Role of neuropilin-2 in the ipsilateral growth of midbrain dopaminergic axons. | 2.54e-05 | 13 | 158 | 3 | 23534961 | |
| Pubmed | Basement membranes in skin are differently affected by lack of nidogen 1 and 2. | 2.54e-05 | 13 | 158 | 3 | 18356808 | |
| Pubmed | Dystroglycan organizes axon guidance cue localization and axonal pathfinding. | 3.23e-05 | 14 | 158 | 3 | 23217742 | |
| Pubmed | 3.23e-05 | 14 | 158 | 3 | 8605874 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | SEMA3F NID2 HSPG2 SLC25A4 SLC25A5 SPTLC1 SNX33 CD320 MDH2 HPDL STT3A NOMO1 PDIA4 THBD FADS3 NOMO2 SEC24B UQCRC2 NOMO3 | 3.49e-05 | 1451 | 158 | 19 | 30550785 |
| Pubmed | 3.74e-05 | 82 | 158 | 5 | 20833797 | ||
| Pubmed | 4.02e-05 | 15 | 158 | 3 | 23821580 | ||
| Pubmed | Aquaporins 8 and 9 as Possible Markers for Adult Murine Lacrimal Gland Cells. | 4.02e-05 | 15 | 158 | 3 | 34540996 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 4.02e-05 | 15 | 158 | 3 | 15895400 | |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | 4.22e-05 | 203 | 158 | 7 | 16916647 | |
| Pubmed | ATR SLC25A4 OBSL1 PEX1 SRPK2 PFAS PAPSS2 SBNO2 ACAD11 AFG3L2 UQCRC2 SCRIB | 4.54e-05 | 650 | 158 | 12 | 38777146 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA3F PLXNA3 HSPG2 ABL1 MED14 FRMD8 PFAS PIGG PRAG1 SBNO2 LIME1 TRIB3 PKD1 PRKDC IGSF3 MVB12B | 4.68e-05 | 1105 | 158 | 16 | 35748872 |
| Interaction | FBXO6 interactions | HSPG2 SLC25A5 SLC25A6 TNC POLR2B SPTLC1 STK38 LAMA3 ITGA6 STT3A NOMO1 SEMA4C LIFR CILP2 NOMO2 AFG3L2 PRKDC UQCRC2 NOMO3 IGSF3 | 5.30e-07 | 717 | 153 | 20 | int:FBXO6 |
| Interaction | FBXO2 interactions | PLXNA3 NID2 HSPG2 SDK2 LAMA3 ITGA6 ADGRV1 CD320 NOMO1 SEMA4C LIFR CILP2 ROBO1 NOMO3 IGSF3 | 5.83e-07 | 411 | 153 | 15 | int:FBXO2 |
| Interaction | TMEM41B interactions | SLC25A5 TMEM115 SPTLC1 STT3A NOMO1 SLC5A6 AFG3L2 PRKDC UQCRC2 | 4.16e-06 | 162 | 153 | 9 | int:TMEM41B |
| Interaction | BRICD5 interactions | 1.78e-05 | 194 | 153 | 9 | int:BRICD5 | |
| Interaction | APOM interactions | 1.80e-05 | 43 | 153 | 5 | int:APOM | |
| Interaction | CLN3 interactions | 2.80e-05 | 115 | 153 | 7 | int:CLN3 | |
| Interaction | SH3BP2 interactions | 3.11e-05 | 48 | 153 | 5 | int:SH3BP2 | |
| Interaction | CEACAM8 interactions | 3.49e-05 | 119 | 153 | 7 | int:CEACAM8 | |
| Interaction | SOCS1 interactions | 6.33e-05 | 177 | 153 | 8 | int:SOCS1 | |
| Cytoband | 19p13.11 | 1.22e-04 | 73 | 158 | 4 | 19p13.11 | |
| GeneFamily | Fibronectin type III domain containing | SDK2 TNC LIFR FNDC7 CSF3R PTPRH PTPRQ ROBO1 ROBO2 TNR IL27RA MYBPC2 | 2.82e-10 | 160 | 111 | 12 | 555 |
| GeneFamily | Immunoglobulin like domain containing | 2.96e-06 | 193 | 111 | 9 | 594 | |
| GeneFamily | Solute carriers | SLC25A42 SLC25A4 SLC25A5 SLC25A6 SLC7A11 SLC2A10 SLC22A16 SLC5A6 SLC14A2 SLC26A6 SLC27A5 | 3.15e-05 | 395 | 111 | 11 | 752 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.09e-05 | 161 | 111 | 7 | 593 | |
| GeneFamily | Aquaporins | 7.80e-05 | 14 | 111 | 3 | 305 | |
| Coexpression | MOOTHA_HUMAN_MITODB_6_2002 | ATP5MC3 SLC25A4 SLC25A5 GALR3 CYP27B1 MDH2 BDH1 SBNO2 ARG2 ABCB8 AFG3L2 HSD3B1 UQCRC2 SDS | 3.64e-07 | 432 | 157 | 14 | M9433 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.40e-06 | 191 | 157 | 9 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.97e-06 | 196 | 157 | 9 | M3008 | |
| Coexpression | GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN | 3.22e-06 | 198 | 157 | 9 | M6841 | |
| Coexpression | NABA_MATRISOME | TPO SEMA3F PLXNA3 HGFAC NID2 HSPG2 AMH CPAMD8 ADAMTS4 TNC MATN3 LAMA3 SVEP1 TGM5 SEMA4C CILP2 FNDC7 NRG3 TNR CCN3 | 3.56e-06 | 1026 | 157 | 20 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | 5.65e-06 | 270 | 157 | 10 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 6.64e-06 | 275 | 157 | 10 | M5884 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 6.85e-06 | 276 | 157 | 10 | M3063 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | SEMA3F NCOA3 ATR SLC25A5 TNC POLR2B STT3A UBR5 AFG3L2 SEC24B MMS19 PRKDC IGSF3 | 7.03e-06 | 481 | 157 | 13 | M3898 |
| Coexpression | NABA_MATRISOME | TPO SEMA3F PLXNA3 HGFAC NID2 HSPG2 AMH ADAMTS4 TNC MATN3 LAMA3 SVEP1 TGM5 SEMA4C CILP2 FNDC7 NRG3 TNR CCN3 | 1.02e-05 | 1008 | 157 | 19 | MM17056 |
| Coexpression | CYCLIN_D1_KE_.V1_UP | 1.85e-05 | 188 | 157 | 8 | M2648 | |
| Coexpression | MOOTHA_MITOCHONDRIA | TPO ATP5MC3 SLC25A4 SLC25A5 CYP27B1 MDH2 BDH1 SBNO2 ARG2 ABCB8 AFG3L2 UQCRC2 | 1.87e-05 | 451 | 157 | 12 | M9577 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | SEMA3F PLXNA3 SPTLC1 OBSL1 STT3A SBNO2 SEMA4C SLC2A10 LIME1 FADS3 PKD1 IGSF3 | 2.13e-05 | 457 | 157 | 12 | M1613 |
| Coexpression | GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP | 2.59e-05 | 197 | 157 | 8 | M8426 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_DN | 2.69e-05 | 198 | 157 | 8 | M4443 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | HSPG2 TPCN2 TMEM115 SPTLC1 OBSL1 ANKH STT3A SBNO2 SEMA4C PDIA4 SLC2A10 THBD SLC5A6 TMEM86A | 6.42e-05 | 681 | 157 | 14 | M5314 |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 7.97e-05 | 171 | 157 | 7 | M2194 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | SEMA3F PLXNA3 SPTLC1 STT3A SBNO2 SEMA4C SLC2A10 LIME1 FADS3 PKD1 IGSF3 | 1.31e-04 | 470 | 157 | 11 | MM1053 |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 3.02e-08 | 192 | 158 | 9 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 184 | 158 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 184 | 158 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 184 | 158 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.09e-07 | 190 | 158 | 8 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 4.26e-07 | 191 | 158 | 8 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-06 | 171 | 158 | 7 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-06 | 171 | 158 | 7 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.48e-06 | 178 | 158 | 7 | 8591a40fced747ac16b3e8ebc7a22dfb3ad76da2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-06 | 181 | 158 | 7 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-06 | 181 | 158 | 7 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.81e-06 | 187 | 158 | 7 | 03de3c2df31bca0dc4e3718bada708d8fe8b69b9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-06 | 189 | 158 | 7 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-06 | 191 | 158 | 7 | 8b34e06c398056e857a10c7653c70c0b1f181692 | |
| ToppCell | Control-Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.53e-06 | 191 | 158 | 7 | 3df5bbdb29bbcbcb8476fdf126b6d4c1ac67d64b | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 5.53e-06 | 191 | 158 | 7 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 5.72e-06 | 192 | 158 | 7 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 5.72e-06 | 192 | 158 | 7 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.92e-06 | 193 | 158 | 7 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.55e-06 | 196 | 158 | 7 | ed818de15f84f7f28bd06fd69d7876710da232a0 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.77e-06 | 197 | 158 | 7 | 66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.77e-06 | 197 | 158 | 7 | 947042f888335c0829d4d5daeb623973eadb3348 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 6.77e-06 | 197 | 158 | 7 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.99e-06 | 198 | 158 | 7 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.99e-06 | 198 | 158 | 7 | e9e98c20ff7b3f3851db86381550ce7085e2db9e | |
| ToppCell | (02)_MMP9/10+|World / shred by cell type by condition | 7.23e-06 | 199 | 158 | 7 | 3f78eddeaa67d3b767aa38de765632166b09a4f0 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Artery-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.47e-06 | 200 | 158 | 7 | 622206c33640cb2694fe158e8dc55515bb7bd4f5 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Artery|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.47e-06 | 200 | 158 | 7 | 5b4a54cd81bc4d9f5e92798362239e1aa1b70bee | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Artery|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 7.47e-06 | 200 | 158 | 7 | 590d1c0f86f136c7e76ea107fbb8ac5ff1164386 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Otof-Sorcs1_(eccentric_SPN,_dSPN-like_markers)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.32e-05 | 47 | 158 | 4 | eef028d66c49406e71387e59bf7dddf5d5247472 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Otof-Sorcs1_(eccentric_SPN,_dSPN-like_markers)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.32e-05 | 47 | 158 | 4 | 6420abf8a0094a1de6dea0670d5820b99edff78d | |
| ToppCell | droplet-Liver-Hepatocytes-21m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 164 | 158 | 6 | c9866a289e120be4066e66275c3beb97ba67cca4 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 164 | 158 | 6 | 90afae3cca108ebfb44ff2ec4adcbb8c68a0bdf2 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 165 | 158 | 6 | 84eca6a0f5e996b6955ae79fa102af239098fe8f | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 165 | 158 | 6 | af59a095ecc6758abc13d763c00e44447c488167 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 166 | 158 | 6 | 4b63ecedf21285974f0d188979fcdced27bf9ef9 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 166 | 158 | 6 | c215c4aede38d355d35fd26cd7ef2c19efecd0e6 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 166 | 158 | 6 | d6d29b0dc1ef471b1227495f349963ab37f22ec4 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.94e-05 | 167 | 158 | 6 | fd84a99ea142d1684cdcf4a88ef1d541760bc78a | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-05 | 169 | 158 | 6 | 735655e75511c5c41aca667909e8bb52a0ad7fc6 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.15e-05 | 169 | 158 | 6 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.15e-05 | 169 | 158 | 6 | 559e98216720e4babf0b0941100f1b485c35b11b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.25e-05 | 170 | 158 | 6 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.25e-05 | 170 | 158 | 6 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-05 | 170 | 158 | 6 | 3229f2a02bfa075aa61118552d0407fc018ab3d1 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.36e-05 | 171 | 158 | 6 | 38a05b5ec8ef8f09a2399994c6b4b9a707918ec1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.47e-05 | 172 | 158 | 6 | c3a99828838af3b85c8c885d69cc8018f55ced50 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-05 | 172 | 158 | 6 | 30916a902c151907745756d14327e24adc34afef | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 175 | 158 | 6 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 175 | 158 | 6 | d67c77eee979ad029e7545f383326f0ff77c6e5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 175 | 158 | 6 | 1d1cdbf3221b03e24eae38afd57cbd6736b37a53 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 3.95e-05 | 176 | 158 | 6 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | B_cells-pDCs|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.95e-05 | 176 | 158 | 6 | ce757de9e09a225f3f96433f103f43619b0e0dda | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-05 | 179 | 158 | 6 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-05 | 180 | 158 | 6 | be10fe5bf7c3a671c42704ce7dd8226ab6896794 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 4.48e-05 | 180 | 158 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-05 | 180 | 158 | 6 | 3b747a517ce75ef2ff09011c037dad7b01ed3e03 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.76e-05 | 182 | 158 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.91e-05 | 183 | 158 | 6 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 5.06e-05 | 184 | 158 | 6 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.37e-05 | 186 | 158 | 6 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.37e-05 | 186 | 158 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.37e-05 | 186 | 158 | 6 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | Mesenchymal_cells-Adipo-CAR|World / Lineage and Cell class | 5.37e-05 | 186 | 158 | 6 | 6ca8ce7ced91d6308b7c056032ffec1b37c974bf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-05 | 187 | 158 | 6 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|Mesenchymal_cells / Lineage and Cell class | 5.53e-05 | 187 | 158 | 6 | e899b906409f3fad69cb3d3c6432c3fd862ae3c1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-05 | 187 | 158 | 6 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.53e-05 | 187 | 158 | 6 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-05 | 188 | 158 | 6 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 5.70e-05 | 188 | 158 | 6 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.04e-05 | 190 | 158 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.04e-05 | 190 | 158 | 6 | 71a00f63fdd4eb4cc6f190d37e7a0417cdaafacb | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-05 | 190 | 158 | 6 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-05 | 190 | 158 | 6 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 191 | 158 | 6 | b94e66ac71e73f46b0323d424e7b8b906751d584 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.22e-05 | 191 | 158 | 6 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.22e-05 | 191 | 158 | 6 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.22e-05 | 191 | 158 | 6 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-05 | 192 | 158 | 6 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.40e-05 | 192 | 158 | 6 | 40f44ac4ab673ee6156abdd2074a60b9de3281ad | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.59e-05 | 193 | 158 | 6 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 6.59e-05 | 193 | 158 | 6 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-05 | 194 | 158 | 6 | be869e186386d03ebb670971dd24fa656b4b0edf | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.78e-05 | 194 | 158 | 6 | efd5efed060edb7f24d59600981bb60ec28ac2ef | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 6.78e-05 | 194 | 158 | 6 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.78e-05 | 194 | 158 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 194 | 158 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Biopsy_Control_(H.)-Immune-pDCs|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 6.98e-05 | 195 | 158 | 6 | 47d139215f0b51f5ea9b5fb09b1100e320e3f1e2 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 195 | 158 | 6 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.98e-05 | 195 | 158 | 6 | cc3d6f98d310e8840ff497d7258c5ccf54e6c624 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.98e-05 | 195 | 158 | 6 | fbc324c3435f32b9ca269d83333faecfe940d7fe | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 6.98e-05 | 195 | 158 | 6 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.98e-05 | 195 | 158 | 6 | b0979c1b5e4576468b8fe4e9027650859e598b34 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.18e-05 | 196 | 158 | 6 | c5fe470f11ee4962bcfb30cddfd8c078af5b1222 | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.18e-05 | 196 | 158 | 6 | 170629b9ae82e9a911b93e8739dcd38176fbecb4 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.18e-05 | 196 | 158 | 6 | a0ba408b802fa6d6e42e6d234b6879fdb1583f81 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.38e-05 | 197 | 158 | 6 | 87eda06344498dc66cac292cf89746dc90b5cf67 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.38e-05 | 197 | 158 | 6 | 62c0a90869431e582bb7bb329e0b0cc59123d3d1 | |
| ToppCell | Severe|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.38e-05 | 197 | 158 | 6 | df3f58b58f82c42c65b0a09c054b669b34502037 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 7.38e-05 | 197 | 158 | 6 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| Computational | Neighborhood of IGF1 | 8.33e-05 | 26 | 98 | 4 | GNF2_IGF1 | |
| Computational | Genes in the cancer module 166. | 1.15e-04 | 53 | 98 | 5 | MODULE_166 | |
| Computational | Genes in the cancer module 256. | 2.26e-04 | 61 | 98 | 5 | MODULE_256 | |
| Computational | Genes in the cancer module 27. | FLT3 GALR3 TNC GRM3 CHRNA4 LIFR THBD ADRA2A CSF3R PTPRH IL27RA | 3.74e-04 | 355 | 98 | 11 | MODULE_27 |
| Drug | Clodronate | 3.22e-07 | 3 | 157 | 3 | DB00720 | |
| Drug | dehydroabietylamine | 1.28e-06 | 4 | 157 | 3 | ctd:C000600819 | |
| Disease | autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology) | 5.24e-07 | 4 | 151 | 3 | DOID:0111517 (implicated_via_orthology) | |
| Disease | Disproportionate short stature | 2.86e-06 | 77 | 151 | 6 | C0878659 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 1.42e-05 | 29 | 151 | 4 | DOID:11984 (implicated_via_orthology) | |
| Disease | Schwartz-Jampel syndrome | 7.78e-05 | 3 | 151 | 2 | cv:C0036391 | |
| Disease | Benign neoplasm of stomach | 8.48e-05 | 17 | 151 | 3 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 8.48e-05 | 17 | 151 | 3 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 8.48e-05 | 17 | 151 | 3 | C0154060 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.20e-04 | 19 | 151 | 3 | DOID:2256 (is_implicated_in) | |
| Disease | Congenital myotonia | 1.55e-04 | 4 | 151 | 2 | cv:CN295225 | |
| Disease | Stomach Carcinoma | 1.63e-04 | 21 | 151 | 3 | C0699791 | |
| Disease | nicotine withdrawal measurement | 3.51e-04 | 27 | 151 | 3 | EFO_0009362 | |
| Disease | Pleocytosis | 3.85e-04 | 6 | 151 | 2 | C0151857 | |
| Disease | Failure to Thrive | 3.85e-04 | 6 | 151 | 2 | C0015544 | |
| Disease | Leukocytosis | 3.85e-04 | 6 | 151 | 2 | C0023518 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 4.91e-04 | 71 | 151 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 5.37e-04 | 7 | 151 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 5.37e-04 | 7 | 151 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 7.62e-04 | 35 | 151 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 1.32e-03 | 616 | 151 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.32e-03 | 616 | 151 | 10 | C0376358 | |
| Disease | Mitochondrial Myopathies | 1.39e-03 | 11 | 151 | 2 | C0162670 | |
| Disease | Adenocarcinoma of large intestine | 1.52e-03 | 96 | 151 | 4 | C1319315 | |
| Disease | Abnormality of the dentition | 1.66e-03 | 12 | 151 | 2 | HP_0000164 | |
| Disease | response to ketamine, dissociation measurement | 1.96e-03 | 13 | 151 | 2 | EFO_0009748, EFO_0009750 | |
| Disease | R-6-hydroxywarfarin to R-warfarin ratio measurement | 2.18e-03 | 106 | 151 | 4 | EFO_0803333 | |
| Disease | Pneumoconiosis | 2.27e-03 | 14 | 151 | 2 | C0032273 | |
| Disease | Bagassosis | 2.27e-03 | 14 | 151 | 2 | C0004681 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 2.27e-03 | 14 | 151 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | Alzheimer disease, visuospatial impairment | 2.27e-03 | 14 | 151 | 2 | EFO_0009752, MONDO_0004975 | |
| Disease | monoclonal gammopathy | 2.55e-03 | 53 | 151 | 3 | EFO_0000203 | |
| Disease | HbA1c measurement | CPAMD8 CYP27B1 PFAS ANKH DALRD3 ADRA2A FADS3 PTPRH SLC22A16 ASB16 | 2.57e-03 | 675 | 151 | 10 | EFO_0004541 |
| Disease | cis/trans-18:2 fatty acid measurement, trans fatty acid measurement | 2.61e-03 | 15 | 151 | 2 | EFO_0006821, EFO_0006824 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 2.61e-03 | 15 | 151 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | basal cell carcinoma | 2.94e-03 | 189 | 151 | 5 | EFO_0004193 | |
| Disease | colorectal mucinous adenocarcinoma | 2.98e-03 | 16 | 151 | 2 | EFO_0009361 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 2.98e-03 | 16 | 151 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | dermatomyositis (is_marker_for) | 3.36e-03 | 17 | 151 | 2 | DOID:10223 (is_marker_for) | |
| Disease | C-reactive protein measurement | SOX5 SEMA3F HGFAC FAM210A PRAG1 LIME1 CILP2 SLC5A6 DNAH17 PKD1 IL1RL1 CCN3 ARMH4 DNAH11 | 3.68e-03 | 1206 | 151 | 14 | EFO_0004458 |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 4.20e-03 | 19 | 151 | 2 | OBA_2045199 | |
| Disease | Multiple Epiphyseal Dysplasia | 4.65e-03 | 20 | 151 | 2 | C0026760 | |
| Disease | X-24309 measurement | 4.65e-03 | 20 | 151 | 2 | EFO_0800872 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LYIPRSTATAALGAA | 946 | Q8NAT2 | |
| IATPARYTVTLGGTS | 196 | Q96ND0 | |
| SPALTRAVEGVQYIA | 561 | P43681 | |
| TAVAGVVSYPFDTVR | 221 | P12236 | |
| PCISSASIVYIGLRD | 186 | P78540 | |
| SGPAVALLVTVTAYT | 176 | Q8IXF9 | |
| ALLVTVTAYTAGPFT | 181 | Q8IXF9 | |
| DTRSVLYVLTGSSVP | 476 | Q96PZ7 | |
| SVPVFIYTSSIEVAG | 116 | P14060 | |
| TSFIPIGRRTYASAA | 36 | Q02338 | |
| VPVVYIAESDGSFLL | 241 | Q9Y4W6 | |
| PSITRVNTAASYGLD | 591 | Q86TY3 | |
| VAYGAITLELASQPV | 316 | Q14832 | |
| SFYGAVERPVDISLS | 151 | P78314 | |
| AVPITAIAGEDYSIA | 2156 | Q8WXG9 | |
| TAVAGLTSYPFDTVR | 221 | P05141 | |
| QTAPLAIATARGYTD | 111 | Q96NS5 | |
| ATPATVSRAGILYVN | 2306 | Q96DT5 | |
| SGPAVALLVTVTAYT | 176 | A6NM10 | |
| ALLVTVTAYTAGPFT | 181 | A6NM10 | |
| EGLPLAVTISLAYSV | 431 | Q16720 | |
| AGSRVAYRPISASVL | 16 | P48201 | |
| GLSPAERSAIYVATV | 136 | Q709F0 | |
| VAGLTAAAYRVTLNP | 31 | Q86Y39 | |
| PLIVAGYNVSGSVRS | 211 | P69849 | |
| GVAYPVRIESSSASL | 2531 | P98160 | |
| GLVIASLENYSPVSR | 46 | P22695 | |
| ADVERYVASVLGLTP | 6 | Q99666 | |
| ADVERYVASVLGLTP | 6 | O14715 | |
| TEVATVYAPALSARA | 251 | Q6ZSG2 | |
| GTVRTVYVAAPALVE | 81 | O15528 | |
| DLVGYSSTRASSVPI | 586 | P56975 | |
| LTAALPTDAGVYVCR | 71 | O75147 | |
| VELAPRSADSGYLVT | 606 | Q9Y5G9 | |
| GLTSVEIIPFRVAAY | 541 | O95340 | |
| IYTRSVVESIASPAV | 216 | O75914 | |
| PLIVAGYNVSGSVRS | 211 | Q5JPE7 | |
| GPADTRVAVVNYAST | 116 | O15232 | |
| VAAYEFTTLTTVPGV | 91 | Q9Y295 | |
| GNSTISIRAPVYLGS | 3096 | Q16787 | |
| SATAPRGVVYKIIDA | 561 | Q96JK4 | |
| NSTGIPYSRIEISAA | 526 | O95528 | |
| ALEASGTLAALYPVA | 506 | Q96T76 | |
| SVSSVGARAADVLVY | 21 | Q9BZ67 | |
| TAVAETQAGRSLPSY | 521 | Q5VTL7 | |
| SRLTLYDIAHTPGVA | 51 | P40926 | |
| PTAYGVIAAAAVLSA | 226 | Q9NPF0 | |
| SVSSVGARAADVLVY | 21 | Q9BZ68 | |
| YLTSIPSVEAASIGF | 86 | Q86YR7 | |
| YLAPSVEGARTTSQA | 171 | Q8IWD5 | |
| LIPAAAGSSRLNYTV | 1151 | P51805 | |
| AIVGNYTAALPTEAA | 481 | Q96PD5 | |
| PAALSAAEGLISYAI | 131 | Q96LB9 | |
| ASTVYGSSPALERQL | 326 | P07202 | |
| PLIVAGYNVSGSVRS | 211 | Q15155 | |
| GVPYRITVTAVSASG | 386 | Q6UWB1 | |
| ASQSIRITGPSVIAY | 251 | A0A1B0GTW7 | |
| AIGVAEPLSISIFTY | 321 | Q00266 | |
| SSSPLRVVGALSAYE | 66 | P03971 | |
| YPDVAVGSLSDSVTI | 486 | P23229 | |
| PFAVILASYGAVARA | 211 | Q8NGU4 | |
| PSLFAVSRYAGEVRT | 616 | Q9Y5F7 | |
| NVSGYSSSLREALVP | 546 | Q04756 | |
| VASRNRAPTGYDVVA | 56 | Q9H7P6 | |
| RPAALVGYTVLSGVA | 146 | Q8N4S7 | |
| PVRVRDAQGAATYAV | 106 | Q96IR7 | |
| ATYAVVSSPAGILSL | 116 | Q96IR7 | |
| SFAIPYAIDVLTTGS | 151 | O60244 | |
| GLEPVSTYSIRVSAF | 1346 | Q9UMZ3 | |
| TAVYVGISSAVPFLI | 371 | Q8NA29 | |
| EDTSPAVLGLAARYV | 126 | Q14112 | |
| ALRPQSSGTVYEAAA | 66 | P36888 | |
| VATFAAGYLLPVAVV | 186 | O60755 | |
| SLAAAYVPVVVDSKG | 56 | X6R8D5 | |
| ASVSGAAYTEIRALV | 901 | Q13535 | |
| VVLPGAVSLRYSGAT | 751 | O75173 | |
| PAAVADSGIYTCIVR | 76 | Q01638 | |
| AVTAISRTPGVTYSD | 546 | O75054 | |
| ISSTAVTRPIATGYG | 56 | Q13099 | |
| LAAYRPEATLGVEVS | 186 | P48745 | |
| ATPATVSRAGILYIN | 2251 | Q9UFH2 | |
| VGSHISLPRAVAYVA | 91 | Q13520 | |
| SGVAILRAYSPESSS | 891 | Q14CM0 | |
| SCIRYVLVTAGPVFT | 1586 | Q5TH69 | |
| TYTLLGDVAAALPVV | 1386 | Q8IZJ3 | |
| PVSRNAAEYLLSSGI | 131 | P00519 | |
| AATEAVAILTATYPV | 271 | Q9HCJ1 | |
| VALVAYNSAGTSRPT | 406 | Q99062 | |
| ALLNSVVYGPERTSA | 71 | Q6PJG2 | |
| LLIYEVSSRFSGVPD | 71 | A2NJV5 | |
| FGAVYSSDEALIPIR | 361 | Q92851 | |
| ERVLSAVAAYATPAS | 96 | Q5D0E6 | |
| SRTALYDLLGVPSTA | 46 | Q96LL9 | |
| TVAPVFLLGESSVEY | 236 | Q9Y5Q0 | |
| PVVSSLADVYAGVDV | 1001 | O95487 | |
| AAAYAARQLGVPATI | 71 | P20132 | |
| SSVPSVVRGAYLSVL | 291 | Q58EX2 | |
| EVLAPSARQYTATGL | 1351 | Q58EX2 | |
| GVYVLAATSRPDLID | 976 | O43933 | |
| GRVTALVGPRATSYT | 356 | P42702 | |
| LVGPRATSYTLVESF | 361 | P42702 | |
| LSGRDVTYTPVAAGL | 2021 | P98161 | |
| DTVAVGLVSSVVVYP | 3321 | P98161 | |
| VASLLERFYDPTAGV | 516 | Q9NUT2 | |
| SVYSGIRVSDNLPVA | 51 | P11309 | |
| RQLAFSTVGTPDYIA | 276 | Q15208 | |
| AAAVSITYGTPFAAR | 186 | P07204 | |
| IRAEGVPASAYRSVS | 336 | Q8IUW3 | |
| RYLTAATASVGSGVP | 211 | O60522 | |
| RNPVIYAVFTSSGSV | 351 | Q13275 | |
| DVTDRLAVLVASVYP | 901 | Q6ZUX3 | |
| VQRSATIGSSPVLYS | 801 | Q8N3X1 | |
| VVSVEFIAPALEGTY | 441 | Q14596 | |
| ATYVAPSATLDIGLQ | 726 | Q8NE09 | |
| AELYPTIVRSLAVGS | 466 | Q86VW1 | |
| SAVAILGVPSEIYRF | 81 | Q9Y289 | |
| SEPLVRGYTTAAAVQ | 211 | Q9BXS9 | |
| ATYSAAFLPVVIGLD | 36 | Q96P88 | |
| VPYSVASAAIPAAAI | 731 | Q8TE76 | |
| PVYRFSLADGTIVTA | 331 | Q9Y6Q9 | |
| FPASYVEIVRSGIST | 51 | Q8WV41 | |
| IAVVPGYISRSVAGS | 151 | P46977 | |
| ELPAGINSIVAIASY | 771 | P30876 | |
| LPLARVVYASATGAS | 411 | Q9Y2G9 | |
| SVLASRFDVSGYPTI | 126 | P13667 | |
| APVSSVALRQSGGYV | 56 | Q15493 | |
| TAGVTGYPRASIART | 256 | Q86VD7 | |
| LDYRALAAVPSAGSV | 1266 | Q14160 | |
| YLVAVVAGPSVTLEA | 641 | Q9C0C4 | |
| LAFVDIGYSSSVTPV | 66 | Q8WZ94 | |
| PIGDVAIVYTATDLS | 616 | Q4LDE5 | |
| SPTGSGVTARIALQY | 271 | Q96EM0 | |
| IASAIPAYSKRGDIV | 171 | O15269 | |
| GTLVAVYAVATPFVT | 46 | Q6P4H8 | |
| GGARATPYSLQVTLT | 36 | P08913 | |
| TAVAGLVSYPFDTVR | 221 | P12235 | |
| RPDAYTALVTATLGG | 801 | Q8IUL8 | |
| AVIFGESIALIYPSS | 266 | Q9NYW3 | |
| PAATAVISLAFGRYI | 136 | Q9UPY5 | |
| PSATRIFVGLVFSAV | 66 | Q8N2M4 | |
| LSGATADDVVYTVLP | 321 | Q9Y2P5 | |
| IVGTRSNDPVAYALA | 231 | P28289 | |
| AVATASRLGPYVLLE | 61 | Q96RU7 | |
| TVRAPGSLVISAYAV | 816 | O15067 | |
| RSIEVLIGAGYSTPA | 551 | P78362 | |
| TVKRYDVGAPSSITI | 256 | Q12893 | |
| LRAGTPYTVTLHGEV | 1316 | P24821 | |
| IRGYRTPVLSAEAST | 1421 | P24821 | |
| YRITFTPSSGIASEV | 716 | Q92752 | |
| PGIQYRVEVAASTSA | 806 | Q9HCK4 | |
| FLVPGIRYSVEVAAS | 841 | Q9Y6N7 | |
| TLSYPSITINVLGAA | 616 | O43548 | |
| RTIYLSSPDSAVGVQ | 486 | Q86YV5 | |
| AQSLSTVGPRLASEY | 376 | O43290 | |
| GTTYRIIANALSSEP | 3331 | P78527 | |
| ALASPSARVSTIGYL | 436 | P35711 | |
| IVQPLDSTRVASYSG | 956 | Q5VWN6 | |
| GAPSRAEQLASVVIY | 2211 | Q9C0G0 | |
| SVFTPRVIGTAVARY | 811 | P52735 | |
| PDGALLATASYDTRV | 266 | Q9Y6I7 | |
| DTYVEIPAVLLTAFG | 876 | Q5H8A4 | |
| ALSVATPFETIYTGL | 331 | Q15849 | |
| EVRGYNSTLTAATAP | 551 | Q9HD43 | |
| LTTYRSIQVGPGAAA | 26 | Q8NHX9 | |
| VSGRAYPAAITILET | 1121 | O95071 | |
| DLAVVYTLGPASFLV | 261 | Q2I0M4 | |
| VSLAASPVVAEYARV | 156 | Q9H400 | |
| LTPLIDRVVVAGYSA | 1051 | Q14324 |